GRB2 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, our recent studies suggest that Grb2 (manuscript submitted) and c-Src [19], both of which showed in vitro and in vivo binding with AQP5, could be some of the candidate adaptor molecules which interact with AQP5 in CML cells.